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ABSTRACT
By interacting with proteins and nucleic acids, the
vast family of mammalian circRNAs is proposed
to influence many biological processes. Here, RNA
sequencing analysis of circRNAs differentially ex-
pressed during myogenesis revealed that circSamd4
expression increased robustly in mouse C2C12 my-
oblasts differentiating into myotubes. Moreover, si-
lencing circSamd4, which is conserved between hu-
man and mouse, delayed myogenesis and lowered
the expression of myogenic markers in cultured my-
oblasts from both species. Affinity pulldown followed
by mass spectrometry revealed that circSamd4 asso-
ciated with PURA and PURB, two repressors of myo-
genesis that inhibit transcription of the myosin heavy
chain (MHC) protein family. Supporting the hypothe-
sis that circSamd4 might complex with PUR proteins
and thereby prevent their interaction with DNA, si-
lencing circSamd4 enhanced the association of PUR
proteins with the Mhc promoter, while overexpress-
ing circSamd4 interfered with the binding of PUR pro-
teins to the Mhc promoter. These effects were abro-
gated when using a mutant circSamd4 lacking the
PUR binding site. Our results indicate that the as-
sociation of PUR proteins with circSamd4 enhances
myogenesis by contributing to the derepression of
MHC transcription.
INTRODUCTION
Even though >90% of the mammalian genome is tran-
scribed, only ∼2% of transcripts encode protein (1). Recent
progress in high-throughput RNA-sequencing and bioin-
formatic analysis has found that many of the noncod-
ing transcripts form covalently closed circular (circ)RNAs.
Tens of thousands of circRNAs have been identified in dif-
ferent cell types, and many display tissue-specific expres-
sion patterns and evolutionary conservation (2,3). CircR-
NAs have been shown to influence cellular processes such as
proliferation, differentiation, senescence, as well as mainte-
nance of cell pluripotency (4–6). Accordingly, several circR-
NAs have been implicated in physiology and disease (7–11).
Despite this progress, the functions of circRNAs in most bi-
ological processes are unknown.
The skeletal muscle comprises nearly 40% of adult tissue,
initially forming during embryonic development and con-
tinually regenerating throughout life via myogenesis (12).
This process involves the specification of mesodermal pre-
cursor cells (satellite cells) into myoblasts, followed by sub-
sequent differentiation and fusion of these cells into mult-
inucleated myotubes. Early myogenesis is governed tran-
scriptionally by the myogenic regulatory factors (MRFs)
MYOD and MYF5, which mediate the initial specifica-
tion of skeletal myoblasts, and by myogenin (MYOG),
MRF4, and myocyte-specific enhancer factors (MEF2A
and MEF2C), which induce differentiation of these spec-
ified cells (13). Later myogenic stages involve the fusion
of the mononucleated myoblasts into multinucleated my-
otubes, the reorganization of cytoskeletal proteins, and the
transcriptional expression of myosin heavy chain (MHC)
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proteins, which function in muscle contraction. In addi-
tion to the myogenic transcription factors, myogenesis is
tightly regulated at the post-transcriptional level through
the actions of RNA-binding proteins (RBPs) and noncod-
ing RNAs (ncRNA) such as miRNAs, lncRNAs, and cir-
cRNAs (14–16).
Numerous chronic age-associated muscular disorders, in-
cluding sarcopenia, osteoarthritis, chronic heart failure, and
chronic obstructive pulmonary disease (17–20), have been
associated with aberrant myogenesis. We previously identi-
fied age-associated changes in circRNAs expressed in mon-
key skeletal muscle with advancing age and proposed that
some of these circRNAs might influence muscle function
during aging (21). Here, we employed RNA-sequencing
analysis to identify circRNAs differentially expressed dur-
ing muscle differentiation and conserved in human muscle
cells. We found that depletion of the highly expressed circ-
Samd4 delayed myogenic progression and influenced late
stages of muscle differentiation. Affinity pulldown followed
by proteomic analysis identified circSamd4-interacting pro-
teins including purine-rich binding proteins (PUR) alpha
and beta (PURA, PURB), two proteins that bind to and
repress myosin heavy chain (Mhc) promoter sequences. We
propose that the progressive elevation in circSamd4 during
myogenesis contributes to sequestering PUR proteins, in
turn facilitating a time-dependent derepression of the Mhc
promoter and the increase in MHC production.
MATERIALS AND METHODS
Cell culture, differentiation, modulation of circSamd4 levels
Proliferating C2C12 myoblasts were cultured in growth
medium (GM), DMEM (Invitrogen) supplemented with
10% fetal bovine serum (Gibco), and antibiotics penicillin
and streptomycin (Life Technologies). Proliferating, sub-
confluent C2C12 myoblasts were induced to differentiate by
culture to high density and switch to differentiation medium
[(DM), DMEM with 2% horse serum] for 3–6 days. Human
myoblasts (22) were cultured in human skeletal muscle GM
(Promocell) consisting of equal parts [DMEM with 10%
FBS, 2 mM L-glutamine, 25 ng/ml FGF, 1 ng/ml EGF,
and penicillin and streptomycin] and [Ham’s F10 media
containing 20% FBS] and antibiotics penicillin and strepto-
mycin, and differentiated as described above with DM me-
dia. For silencing, 50 nM of control (Ctrl) or circSamd4 siR-
NAs (IDT) were transfected using Lipofectamine® 2000
(Thermo Fisher Scientific) into proliferating myoblasts 12
h before inducing differentiation. For overexpression, 1 g
of empty vector pcDNA3, pcDNA3-circSamD4 or deletion
mutant pcDNA3-circSamD43 was transfected by electro-
poration (Amaxa Biosystems™) before inducing differenti-
ation.
Identification of circRNA from RNA-seq analysis
The RNA from GM and DM cells was purified using the
miRNeasy Mini kit (Qiagen) following the manufacturer’s
instructions. The RNA quality and quantity were assessed
with the Agilent 2100-Bioanalyzer followed by removal of
rRNA with the rRNA Depletion Nano kit (Qiagen). The
cDNA library was prepared with the Ovation RNA-Seq
System V2 (NuGEN) kit, and sequencing was performed
on an Illumina HiSeq 2500 instrument (23); data are de-
posited in GSE92632 and GSE136004. Sequencing reads
were mapped to the mouse genome (mm9) using TopHat2
(version 2.0.14) followed by identification of non-linear fu-
sion junction reads using TopHat2. CircRNAs expressed
in GM and DM samples were identified with the CIRCex-
plorer program (v1.10) as described previously (23).
RNA isolation and reverse transcription followed by quanti-
tative PCR (RT-qPCR) analysis
RNA was isolated using TRIzol (Thermo Fisher Scientific)
and subjected to reverse transcription (RT) and real-time
quantitative (q)PCR analysis. After sequencing, divergent
primers were designed to measure the relative expression
levels of circRNAs and identify the junction sequence. To-
tal RNA (2 g) isolated from proliferating or differentiated
cells was either left untreated or treated with RNase R (20
units, Epicentre) for 30 min at 37◦C; RNA samples were
then assayed by RT-qPCR analysis. Copy number was cal-
culated by comparing Ct values of circSamd4 with the con-
centration of transcripts of known abundance in cells, as-
suming 1500 copies of Gapdh mRNA per cell; these esti-
mates were comparable to those described (24,25). Forward
and reverse primers (Supplementary Table S1) were used to
sequence PCR products and identify the junction sequence.
Expression of circRNAs in old and young human skeletal
muscle
Quadriceps skeletal muscle was collected from lean elderly
individuals (age 79 years ± 2; n = 7) intraoperatively during
total knee arthroplasty surgery, and from lean young adults
(age 25 years ± 4; n = 7) using a Bergström needle (UK
Research Ethics Committee 14/ES/1044). The muscle tis-
sue was snap-frozen in liquid nitrogen and ∼100 mg ground
into a fine powder using a pestle and mortar under liquid ni-
trogen. Powdered tissue was immediately transferred to 1 ml
of Trizol® reagent (Thermo Fisher Scientific) and homog-
enized using a Qiagen Tissue Ruptor. Total RNA was then
extracted as described in the manufacturer’s protocol (Tri-
zol, Thermo Fisher Scientific) and resuspended in 30 l of
RNase-free water (Thermo Fisher Scientific). RNA concen-
tration was quantified using a Nanodrop 2000 (Life Tech-
nologies).
For reverse transcription (RT), cDNA was synthesized
from 60 ng of template RNA using a Tetro cDNA Synthe-
sis Kit (Bioline) with random hexamers, as per the manu-
facturer’s instructions. Relative RNA abundance was de-
termined by two-step RT-qPCR analysis normalized to
GAPDH mRNA levels; qPCR analysis was performed us-
ing a SensiFAST™ SYBR® No-ROX Kit (Bioline) follow-
ing the manufacturer’s protocol, using the primers listed
in the Supplementary Figure S1; for GAPDH mRNA, the
primers (sequence not disclosed) were from PrimerDesign
Ltd. All reactions were performed using a Bio-Rad cycler
(Bio-Rad) with a total reaction volume of 5 l. Samples
were assayed in triplicate and a non-template control was
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Plasmids
Briefly, plasmids to overexpress the circSamd4 (pcDNA3-
circSamd4) and deletion mutant circSamd4Δ3 (pcDNA3-
circSamd43) were constructed by cloning the circSamd4
full and truncated sequences in the circRNA mini vector
ZKSCAN1 (24) (Addgene #60649). Genomic DNA was
isolated using DNeasy Blood & Tissue Kit (69504, Qiagen)
and 25 ng of genomic DNA was used to amplify ∼519-bp
genomic sequences upstream and downstream of circSamd4
genomic coordinates using forward and reverse primers
actgGGATCCTCGTGCTTGCGCCGGTTCCAA and ac
tgaagcttGAATCATTAACCAATGGCAAC, respectively.
The PCR products were cloned into the pcDNA3.0 cir-
cRNA mini vector ZKSCAN1. Constructs were verified by
sequencing.
Antisense oligomer (ASO) pulldown and mass spectrometry
analysis
For ASO pulldown, whole-cell lysates were incubated with
3 g of a biotinylated control ASO (5′Biot-TTGGAACC
GGCGCAAGCACGAGAATCATTAACCAATGGCA),
or an ASO complementary to the circSamd4 junction (Biot-
TGGAACCGGCGCAAGCACGAGAATCATTAACC
AATGGCAA) in 1× TENT buffer (10 mM Tris–HCl at
pH 8.0, 1 mM EDTA at pH 8.0, 250 mM NaCl, 0.5%
[v/v] Triton X-100) containing fresh protease and RNase
inhibitors for 1 h at 25◦C with rotation. The biotin-ASO
complexes were then pulled down following addition of
Streptavidin-coupled Dynabeads (50 l, Invitrogen) and
incubation for 30 min at 25◦C with rotation. After exten-
sively washing the Dynabeads, the samples were divided
such that RNA and protein were isolated using TriPure
(Sigma-Aldrich) and 2× SDS elution dye, respectively,
added directly to the washed Dynabead-biotin-ASO com-
plexes. The enrichment of RNAs in the circSamD4-ASO
pulldown was assessed by RT-qPCR analysis and the
circSamD4-ASO-associated proteins were subjected to
mass spectrometry analysis. The presence of these enriched
proteins was confirmed by Western blot analysis with
and without digestion with RNase A, RNase R or both
RNases.
Mass spectrometry raw data files were collected from
analysis of each of four pulldown samples from human
myoblasts and from each of four pulldown samples from
mouse myoblasts. Proteins were searched against the Hu-
man UniProtKB protein sequence database (20 608 entries,
2016) and the mouse UniProtKB mouse protein sequences
database (16 685 entries, 2016), respectively, obtained from
NCBI website using the Proteome Discoverer 1.4 software
(Thermo Scientific), using the SEQUEST and percolator al-
gorithms. The searches were performed with the following
parameters: Carbamidomethylation (+57.021 Da) of cys-
teines was fixed modification, and Oxidation and Deami-
dation Q/N-deamidated (+0.98402 Da) were set as dynamic
modifications; the minimum peptide length was specified to
be five amino acids; the precursor mass tolerance was set
to 15 ppm, and fragment mass tolerance was set to 0.05
Da. The maximum false peptide discovery rate was speci-
fied as 0.01. The resulting Proteome Discoverer Report and
assembled proteins with peptides sequences and matched
spectrum counts are summarized in Supplementary Table
S2.
Western blot analysis
Whole-cell lysates prepared in RIPA buffer were separated
by SDS-PAGE and transferred onto nitrocellulose mem-
branes (Invitrogen iBlot Stack). Incubations with primary
antibodies recognizing MHC, MYOG, HSP90, LMNB2
(Lamin B) (Santa Cruz Biotech), MEF2C (Millipore),
PURA, PURB, YB1, YBOX3 (Abcam) and HNRNPM
(Invitrogen) were followed by incubations with the appro-
priate secondary antibodies conjugated with horseradish
peroxidase (GE Healthcare). Signals were developed us-
ing Enhanced Chemiluminescence (ECL), and digitized im-
ages were captured using Kwik Quant Imager (Kindle Bio-
sciences).
Immunofluorescence and single-molecule in situ hybridization
microscopy
Cells were plated in 35-mm imaging dishes with glass bot-
toms (Idibi) in 100 l PBS, fixed with 100 l of 4%
paraformaldehyde for 15 min at room temperature, washed
twice with 100 l of PBS, permeabilized and blocked with
0.2% Triton X-100 and 1% goat serum, incubated with
50 l of anti-myosin antibody (1:500 Santa Cruz Biotech)
and washed twice in PBS, incubated with 50 l anti-mouse
Cy3/AlexaFluor488 secondary antibody (Thermo Scien-
tific), diluted 1:300 in PBS, and finally washed twice in
PBS. Nuclei were stained using ProLong® Gold Antifade
Mountant with DAPI (Thermo Scientific) and signals were
visualized using a confocal microscope (ZEISS 710 LSM or
880 LSM) using a 65× objective for image acquisition.
For single-molecule in situ hybridization analysis, tar-
get probe sequences (BaseScope), preamplifier, amplifier,
wash buffer, and target retrieval buffers are proprietary
(Advanced Cell Diagnostics). Undifferentiated C2C12 my-
oblasts were harvested by standard methods, counted, and
seeded in glass-bottom dishes (Cellvis, 55 mm, #0) at
300 000 cells per dish and cultured at 37◦C/5% CO2.
Twenty-four hours after seeding, undifferentiated cells were
fixed (undifferentiated controls) or media was changed to
DMEM with 2% horse serum and Penicillin/Streptomycin
for differentiation. Differentiation proceeded for 4 days be-
fore fixation. Samples were fixed in 10% neutral buffered
formalin for 30 min at 25◦C, washed three times with
PBS, and dehydrated in 50%, then 70%, and then 100%
ethanol. Fixed and dehydrated samples were stored in 100%
ethanol at –20◦C until staining. Samples were rehydrated
in 70% ethanol, followed by 50% ethanol and finally in
PBS. Samples were incubated with hydrogen peroxide for
10 min at 25◦C; after rinsing twice in PBS, samples were
hybridized and stained following the manufacturer’s rec-
ommendations. Briefly, samples were treated with Protease
III (ACD Bio) at 1:15 in PBS for 10 min at 25◦C fol-
lowed by rinsing in twice in PBS. Hybridization cassette
(ACD Bio) and HybEZ oven (ACD Bio) were used for sub-
sequent hybridization, preamplification and amplification.
Single ZZ probes (ACD Bio, BaseScope) targeting linear
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- Red) were designed to target outside the circularized se-
quence or to the backsplice junction, respectively. Samd4
mRNA or positive control [Ppib (Ch1) or Polr2a (Ch2)]
probes were hybridized in the HybEZ oven set at 40◦C for
2 h, followed by preamplification and amplification steps
based on the ACD protocol. Chromogenic detection was
performed using Duplex Green/Fast Red (ACD). Samples
were then counterstained with hematoxylin 7211 (Richard
Allen) for 10 s, rinsed briefly in water, then in 0.02% ammo-
nia for 30 s, followed by another rinse with water. Cover-
slips were added with mounting medium (Vectamount) and
cured for 24 h before imaging. Brightfield images were taken
at 20× or 40× with a Nikon upright microscope equipped
with a digital RGB camera.
Ribonucleoprotein immunoprecipitation (RIP) analysis
The association of circSamd4 with endogenous PURA and
PURB in cells was analyzed by ribonucleoprotein (RNP)
immunoprecipitation (RIP) as described (27). Briefly, cells
were lysed in polysome extraction buffer (PEB; 20 mM Tris–
HCl at pH 7.5, 100 mM KCl, 5 mM MgCl2 and 0.5% NP-
40) supplemented with RNase and protease inhibitors. The
cytoplasmic lysates were incubated with PURA (Abcam)
and PURB (Abcam) or control IgG (Santa Cruz Biotech)
antibodies at 4◦C followed by incubation with protein-A-
sepharose for 2 h at 4◦C with rotation. After washes with
ice-cold NT2 buffer [50 mM Tris–HCl (pH 7.5), 150 mM
NaCl, 1 mM MgCl2, 0.05% NP-40], the RNA in the RNP
complexes was isolated using TriPure and used for RT-
qPCR analysis as described above.
Biotin pulldown analysis
C2C12 whole-cell lysates (200 g) were incubated with 250
ng of non-overlapping biotinylated RNA fragments (F1 to
F8) custom-made from IDT to cover the entire sequence
of circSamd4 for 30 min at 25◦C with rotation. Complexes
were isolated with Streptavidin-coupled Dynabeads (Invit-
rogen) and the pulldown material was analyzed by western
blot analysis using PURA and PURB antibodies.
Cell fractionation
Fractionation of nuclear and cytoplasmic components of
C2C12 was performed according to the manufacturer’s in-
structions (NE-PER kit, Thermo Fisher ScientificNE-PER
kit, Thermo Fisher ScientificNE-PER kit, Thermo Fisher
ScientificNE-PER kit, Thermo Fisher Scientific). The cyto-
plasmic and nuclear fractions were subjected to analysis of
protein, RNA, and ribonucleoprotein complexes.
Luciferase assays
The dual MHC promoter reporter construct was obtained
from GeneCopoeia and contains the MHC promoter driv-
ing expression of Gaussia luciferase with an SV40 promoter
driving expression of Renilla luciferase. The reporter plas-
mid (pMH2-LUC-Renilla) (MPRM31645-PL01) (500 ng)
along with 1 g of either empty vector (pcDNA3), deletion
mutant (pcDNA3-circSamd43) or wild-type (pcDNA3-
circSamd4) plasmids, were transfected using Lipofectamine
2000® in 0.3 × 106 pre-seeded cells in a six-well plate; cells
were harvested 48 h later in PLB lysis buffer (Promega) and
RLuc and GLuc activities were measured by Dual Glo lu-
ciferase assay (Promega) following the manufacturer’s pro-
tocol.
ChIP-qPCR analysis
ChIP assays were performed using a CHIP-IT High sen-
sitivity kit (Active Motif, Inc.) as instructed by the manu-
facturer. Briefly, differentiated C2C12 cells were crosslinked
with 1% formaldehyde for 10 min at 25◦C, washed, and
treated with glycine Stop-Fix solution. After resuspending
in cell lysis buffer and incubating on ice for 10 min, pellets
were sonicated to generate genomic DNA fragments. The
chromatin was incubated for 16 h at 4◦C with anti-PURA,
anti-PURB (Abcam), or control IgG (Santa Cruz Biotech-
nology) antibodies. Protein G beads were then added to the
antibody-chromatin complex and incubated for 3 h at 4◦C.
After extensive washes, the immunoprecipitated DNA com-
plexes were eluted from the beads. DNA was purified by
proteinase K digestion and the presence of Mhc II promoter
(−270 to −450) regions as well as negative control Syn2 re-
gion (TTS +200) (primers listed in Supplementary Table S1)
were measured by qPCR analysis following the percentage
input method as described (28,29).
Statistical analysis
All experiments were repeated at least 3 times unless other-
wise stated. Quantitative data are represented as the mean
± SEM, and compared statistically by unpaired student’s t
test, using Prism GraphPad (7.0). Statistical significance is
indicated in the figures as * (P < 0.05) and ** (P < 0.005).
Dedicated statistics were applied to RNA-seq data analysis
as specified in the legends.
RESULTS
The levels of conserved circRNA circSamd4 increase in dif-
ferentiated myoblasts
We used the mouse C2C12 myoblast model of myogenesis
to investigate circRNAs implicated in skeletal muscle differ-
entiation. C2C12 cells proliferate rapidly in normal growth
media (GM), but upon reaching confluency and exposure
to differentiation media (DM) in low serum, they stop di-
viding and progressively fuse, becoming multinucleated my-
otubes (myofibers) with a contractile phenotype (Figure 1A,
top). To identify circRNAs differentially expressed during
myogenesis, total RNA was isolated from C2C12 GM and
DM (3 days) cultures and the circRNAs were identified by
RNA-Seq as described (Materials and Methods) (Figure
1A, schematic; deposited in GSE92632 and GSE136004).
The circRNAs were identified by the CIRCexplorer algo-
rithm.
To monitor this myogenesis model, we studied the ex-
pression levels of myogenic markers MEF2C and MYOG,
which regulate transcriptionally the myogenic protein ex-
pression program. The expression levels of these myogenic
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Figure 1. circRNAs expressed differentially during myogenesis. (A) Myoblast differentiation program; phase-contrast micrographs depicting cultures of
C2C12 mouse myoblasts in proliferating conditions [growth medium (GM)], in early myogenesis after 24 h in differentiation medium (DM), and in late
myogenesis, including myotubes, after 72 h in DM. Schematic, total RNA was prepared from proliferating C2C12 cells (GM) and from C2C12 cultures
differentiating for 72 h (DM); after digestion of linear RNA, RNA pools enriched in circRNAs were sequenced (GSE92632 and GSE136004), and the
circRNAs most highly expressed and most differentially abundant between GM and DM were validated by reverse transcription (RT) followed by real-time
quantitative (q)PCR analysis. (B) Expression levels of myogenic markers Myog, Mef2c, Mhc mRNAs in C2C12 cultures, as assessed by RT-qPCR analysis.
mRNA levels were normalized to the levels of housekeeping transcript Gapdh mRNA. (C) Expression levels of the indicated circRNAs, chosen among
the most differentially abundant in DM relative to GM and most highly expressed overall. RT-qPCR analysis was performed by using divergent primers
(Materials and Methods) in proliferating (GM) and differentiated (DM, 72 h) cultures. mRNA levels were normalized to the levels of housekeeping
transcript Gapdh mRNA. Bottom, representative PCR products on 2% agarose gels; product specificity was assessed from reactions carried out in the
presence or absence of reverse transcriptase (RT). (D) Quantification of copy numbers of circSamd4 in C2C12 cultures in GM (per cell) and DM (per
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chain (MHC), were monitored by reverse transcription
(RT) followed by real-time quantitative (qPCR) analysis. As
shown, the corresponding mRNAs were drastically higher
in C2C12 cultures by 3 days in DM relative to proliferating
C2C12 (GM) cultures (Figure 1B, graph).
Among the circRNAs upregulated in differentiated
C2C12 cells, we validated circRNAs that were abundant
in this paradigm and those that were highly enriched in
DM relative to GM. The levels of a subset of the vali-
dated circRNAs is shown (Figure 1C, including represen-
tative PCR products). We focused further efforts on circ-
Samd4 (circID-mmu circ 0000529, hsa circ 0004846), a cir-
cRNA derived from exon 3 of the mouse gene Samd4
(NM 001037221.2; exon 2 in other transcript variants from
the same mouse gene) that encodes the RBP SAMD4, for
a number of reasons. There is 93% sequence similarity be-
tween human circSAMD4 (circSAMD4A) and mouse circ-
Samd4 by BLAT analysis using circBase, indicating that it
is conserved between both species (Supplementary Figure
S1A). Moreover, in the human myoblast line KM155 (22),
expression of circSAMD4 increased similarly with myogen-
esis (DM relative to GM conditions; Supplementary Figure
S1B) and followed similar kinetics (Supplementary Figure
S1C). In addition, circSAMD4 expression levels increased
with age in human skeletal muscle, while SAMD4 mRNA
levels only changed moderately with age (Supplementary
Figure S1D). Other connections to myogenesis include: (i)
SAMD4 protein suppressed hallmarks of myotonic dystro-
phy (30); (ii) mutation in the mouse Samd4 gene caused my-
opathy and uncoupled mitochondrial respiration (31); (iii)
loss of SAMD4 in mice resulted in multiple developmental
defects, including delayed bone development and decreased
osteogenesis (32) and (iv) circSAMD4 was recently impli-
cated in the enhanced proliferation and stemness traits of
osteosarcoma cells (33). The number of circSamd4 copies in
C2C12 myoblasts as well as the nucleus-equivalent copies in
C2C12 myotubes was estimated as explained in Materials
and Methods and revealed ∼3–4 copies of circSamd4 per
cell in GM populations, and ∼45 copies of circSamd4 per
cell/nucleus-equivalent in DM conditions (Figure 1D).
circSamd4
circSamd4 is generated by circularization of exon 3 of
the Samd4 gene located on chromosome 14 (mm9),
mmu circ 0000529. It is 519 nucleotides long and arises
from head-to-tail splicing of exon 3 from NM 001037221.2,
chr14 (hg19), region 47635951–47636470 (Figure 2A). In
humans, circSAMD4 arises from backsplicing of exon 3 of
SAMD4A pre-mRNA (hsa circ 0004846, NM 015589.6); it
is also located on chromosome 14, 55168779–55169298 and
is 519 nucleotides long. Of note, the same exon is exon 2
in other transcript variants from the same mouse and hu-
man genes. The circSamd4 PCR product was sequenced to
verify the presence of the backspliced junction (Figure 2A).
Digestion using RNase R to degrade the linear RNA de-
pleted almost all Samd4 mRNA, but not circSamd4 (Fig-
ure 2B), serving to confirm the circular nature of circSamd4.
Despite the observed ∼14-fold increase in circSamd4 levels
(Figures 1C and 2C) during myogenesis, Samd4 mRNA lev-
els increased only 3-fold, suggesting that circSamd4 expres-
sion was selectively upregulated during myogenesis (Fig-
ure 2C). The relative distribution of circSamd4 in the nu-
cleus and cytoplasm of C2C12 myoblasts and differenti-
ated C2C12 myotubes was first assessed by RT-qPCR anal-
ysis, and included measurement of control transcripts Actb
mRNA and lncRNA 7sk to monitor the preparation of cy-
toplasmic and nuclear RNAs, respectively. As shown (Fig-
ure 2D), circSamd4 levels increased markedly overall with
differentiation, and it was found in both compartments, but
was predominantly cytoplasmic.
This general pattern of distribution was verified by visu-
alizing circSamd4 as well as Samd4 mRNA in proliferat-
ing and differentiated C2C12 cultures using the BaseScope
single-molecule in situ hybridization (Materials and Meth-
ods). As shown in Figure 2E, Samd4 mRNA signals were
more abundant than circSamd4 signals in proliferating my-
oblasts. By contrast, circSamd4 signals increased overall
during differentiation, and were found in both the nuclei
and the cytoplasm of myotubes, but were more abundant in
the cytoplasm.
circSamd4 promotes myogenesis
To investigate the biological function of circSamd4 in my-
oblast differentiation, we designed several small interfer-
ing (si)RNAs targeting circSamd4, each spanning the back-
splice junction (Figure 3A). Transfection of each of the
three siRNAs reduced circSamd4 levels significantly, but
siRNA3 displayed the most potent reduction and did not
suppress the levels of linear counterpart Samd4 mRNA or
the circRNA circFn1 (Figure 3A and Supplementary Figure
S2A). Given that circSamd4-directed siRNA1 and siRNA2
reduced Samd4 mRNA levels moderately in C2C12 cells
(Figure 3A, Supplementary Figure S2A–C), circSamd4
siRNA3 was chosen for subsequent studies.
After reducing circSamd4 levels by transfection with circ-
Samd4 siRNA followed by exposure to DM conditions,
microscopic analysis revealed that silencing circSamd4 de-
layed myotube formation (Figure 3B). The activity levels of
the myogenesis marker creatine kinase (CK) (Figure 3C),
as well as the abundance of the myogenic markers Myog,
Mef2c and Mhc mRNAs (Figure 3D) were also decreased
when circSamd4 was silenced. These results suggest that
circSamd4 contributes to the progression through myoge-
nesis. In human KM155 myoblasts, knockdown of circ-
SAMD4 by siRNA3 similarly suppressed myogenesis, as
determined by monitoring the levels of SAMD4, MYOG,
and MHC mRNAs as well as CK activity (Supplemen-
tary Figure S2D–G), suggesting that circSAMD4 also pro-
moted human myogenesis. Immunofluorescence analysis
provided additional evidence that myogenesis, as assessed
by the myogenic marker MHC, was impaired in human my-
oblasts following circSAMD4 silencing (Figure 3E). West-
ern blot analysis further revealed that MHC and other myo-
genic markers (MYOG, MEF2C) were also reduced in hu-
man myoblasts in DM conditions after circSAMD4 siRNA
transfections (Figure 3F). We then assessed whether ectopic
overexpression of circSamd4 in C2C12 influenced myogen-
esis by employing an expression vector designed to specifi-
cally express circRNAs (Materials and Methods). Although
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Figure 2. Characterization of circSamd4. (A) Schematic of exon 3 of Samd4 mRNA, located on mouse chromosome 14 and giving rise to a 519-nucleotide
long circSamd4, and detail of the sequence junction. (B) RT-qPCR results showing the abundance of circSamd4 and Samd4 mRNA in total RNA from
C2C12 cells (GM) that were either left untreated or treated with RNase R. RNA levels were normalized to the levels of Gapdh mRNA. (C) Relative
levels of Samd4 mRNAs as measured by RT-qPCR analysis in GM and DM (72 h) C2C12 cultures. RNA levels were normalized to the levels of Gapdh
mRNA in the same samples. (D) Relative levels of circSamd4 in the nuclear (Nuc) and cytoplasmic/sarcoplasmic (Cyto) compartments of C2C12 GM
and DM (72 h) cultures; the quality of the fractionation was assessed by monitoring the levels of a predominantly cytoplasmic transcript (Actb mRNA)
and a predominantly nuclear lncRNA (7sk). (E) Brightfield micrographs to visualize circSamd4 (red) and Samd4 mRNA (blue) in proliferating (GM) and
differentiated (DM) C2C12 cultures using the BaseScope single-molecule detection system (Advanced Cell Diagnostics, CA) (Materials and Methods).
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Figure 3. Silencing circSamd4 reduces the levels of myogenic markers. (A) Schematic representation of 3 siRNAs designed to target the circSamd4 junction.
RT-qPCR analysis of the indicated circular and linear RNAs; C2C12 in GM were transfected with siRNAs, 8 h later the medium was switched to DM
and 48 h after that, cells were collected for analysis. RNA levels were normalized to the levels of Gapdh mRNA. (B–D) Effect of silencing circSamd4
on C2C12 differentiation. Ctrl and circSamd4 siRNAs were transfected into C2C12 (GM) cells and differentiation was initiated 24 h later (time 0 h); 48
and 72 h into DM, phase-contrast micrographs were taken to monitor myotube formation (B), the levels of creatine kinase (CK) were measured at 0, 24,
48 and 72 h (C), and RNA was extracted to measure by RT-qPCR analysis the levels of circSamd4 as well as myogenic markers Myog, Mef2c, and Mhc
mRNAs, normalized to Gapdh mRNA levels (D). (E, F) The effect of silencing circSAMD4 in human KM155 myoblasts (Supplementary Figure S1) on
myogenesis was measured by immunofluorescence analysis of the myotube marker MHC in DM (72 h); nuclei were labeled with DAPI (E), and the levels
of the myogenic proteins MHC, MYOG, and MEF2C were measured by western blot analysis (F). (G, H) Forty-eight hours after transfecting pcDNA3
(empty control) or pcDNA3-circSamd4 into C2C12 cells, RT-qPCR analysis was used to assess the expression levels of circSamd4 and Samd4 mRNA (G)
as well as those of myogenic markers Myog, Mef2c, and Mhc mRNAs, which were normalized to the levels of Gapdh mRNA (H). Data in (A, C, D, G, H)
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C2C12 cells was modest (Figure 3G, left), it enhanced Mhc
mRNA levels (Figure 3H), while it did not raise endoge-
nous Samd4 mRNA levels or ectopic linear exon 3 levels
(Figure 3G, right; Supplementary Figure S3). Collectively,
these data further support the notion that circSamd4 con-
tributes to myogenesis.
circSamd4 associates with PURA and PURB, transcriptional
repressors of MHC production
To investigate how circSamd4 modulates myogenesis,
we sought to identify interacting partners, specifically
circSamd4-associated proteins. We designed an antisense
oligomer (ASO) complementary to the region spanning the
circSamd4 junction region in order to pull down the en-
dogenous circSamd4 from C2C12 myoblasts (Figure 4A,
left) as well as circSAMD4 from human KM155 myoblasts
(Supplementary Figure S4). Following pulldown and con-
firmation by RT-qPCR analysis that circSamd4 was selec-
tively enriched in the pulldown material (Figure 4A, right),
while Samd4 mRNA was not enriched, we identified the
associated proteins by mass spectrometry analysis (Figure
4B). Comparison of the ∼380 putative interacting proteins
in mouse myoblasts and the ∼75 putative interacting pro-
teins in human myoblasts (Supplementary Figures S4A, B
and Supplementary Table S2) revealed a total of 53 pro-
teins enriched in both the circSamd4 (mouse myoblasts) and
circSAMD4 (human myoblasts) pulldowns preferentially in
DM relative to GM (Figure 4B and Supplementary Ta-
ble S2). Gene Ontology (GO) analysis revealed that some
of the shared 53 proteins were capable of binding DNA
and/or RNA (Figure 4C). Phenotype cluster analysis fur-
ther showed that the proteins enriched in both groups play
key roles in RNA processing (Supplementary Figure S4C).
Among the shared proteins, those displaying maximum
peptide counts and playing potential roles in myogenesis or
skeletal muscle metabolism included two candidates in the
PUR family, PURA (Pur) and PURB (Pur) (Figure 4D).
These proteins were particularly interesting, as previous re-
ports had suggested that PURA and PURB, which bind
both RNA and DNA elements, were capable of binding the
proximal promoters of the myosin heavy chain (Mhc) pro-
moter in C2C12 cells and negatively regulated MHC pro-
duction (34). Additionally, PUR proteins regulated MHC
production transcriptionally in cardiac myocytes and were
proposed to mediate a cardiac-restricted MHC production
by preventing its expression in non-muscle cells (35).
We confirmed the interactions of PUR proteins with circ-
Samd4 using two different assays. First, we carried out
pulldown analysis using ASOs, streptavidin-coated beads,
and C2C12 lysates (GM and DM), followed by PURA
and PURB western blot analysis. As shown in Figure 4E,
circSamd4-directed ASO but not Ctrl ASO pulled down
PURA and PURB, and this binding was increased in DM
conditions. Other nucleic acid-binding proteins identified
in the screen, including YBOX1 and YBOX3 were not en-
riched after testing of individual proteins in the circSamd4
ASO pulldown samples (Supplementary Figure S4D), per-
haps because YBOX proteins might interact with PUR pro-
teins instead, as shown previously (36). Additionally, low
levels of HNRNPM were recovered in both ASO frac-
tions (Supplementary Figure S4D). We also confirmed that
PUR RNP complexes contained circSamd4 and not Samd4
mRNA by digesting the samples with RNase A (which de-
grades all RNAs) and/or RNase R (which degrades linear
RNAs preferentially). As shown in Figure 4F, PURA and
PURB were no longer present if the complex was digested
with RNase A, but they remained in the complex after di-
gestion with RNase R, supporting the notion that they as-
sociated with the circular RNA.
Second, we studied these interactions by performing ri-
bonucleoprotein (RNP) immunoprecipitation (RIP) analy-
sis using antibodies that recognized PURA or PURB (Sup-
plementary Figure S4E) and lysates from differentiated
C2C12 cultures under IP conditions that preserved native
complexes. We found a 12- to 14-fold enrichment in the lev-
els of circSamd4 RNA in PURA and PURB immunoprecip-
itated (IP) samples relative to the levels of circSamd4 in the
IgG IP samples (Figure 4G); importantly, Samd4 mRNA
was moderately enriched in PURB RIP samples (although
not in PURA RIP samples) (Figure 4G). The abundant
transcript Gapdh mRNA, encoding the housekeeping pro-
tein GAPDH, was not enriched in the IP materials, sup-
porting the specificity of the association of circSamd4 with
PURA and PURB (Figure 4G). After fractionating nuclear
and cytoplasmic compartments, RIP analysis revealed that
PURA and PURB were capable of interacting with circ-
Samd4 in both the nucleus and the cytoplasm (Figure 4H).
As shown in Supplementary Figure S4F, the levels of PURA
and PURB increased with differentiation, and in DM they
were detected in both compartments.
In control experiments, additional circRNAs that were
initially identified as being upregulated during DM (Figure
1C) were not significantly enriched in PURA or PURB RIP
samples (Supplementary Figure S5A), and YBOX3 RIP
analysis did not show significant binding to circSamd4 or
Samd4 mRNA (Supplementary Figure S5B). Finally, the
levels of PURA and PURB, as well as the correspond-
ing mRNAs, increased slightly with differentiation (Supple-
mentary Figure S5C,D). Taken together, these data indicate
that PURA and PURB preferentially associate with circ-
Samd4 during myogenesis.
A specific region in circSamd4 promotes efficient binding of
PUR proteins
In order to map the region(s) of interaction between circ-
Samd4 and PUR proteins, we prepared nonoverlapping bi-
otinylated RNA fragments spanning the body of the cir-
cRNA (Materials and Methods). After incubation of each
biotinylated RNA with whole-cell lysates prepared from dif-
ferentiated C2C12 cultures, pulldown analysis using strep-
tavidin beads followed by PURA and PURB western blot
analysis revealed that both proteins associated most avidly
with segment 3 (Figure 5A); we also observed weak bind-
ing of PURA to segments 6–8 (Figure 5A). The overall
RNA-binding propensity and the prediction of potential
RNA-binding regions of these PUR proteins were assessed
using catRAPID analysis (37) (Supplementary Figure S6),
yielding an overall interaction score of approximately 0.6
and supporting the observed RNA-binding properties of
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Figure 4. circSamd4 interacts with transcription factors PURA and PURB. (A) Left, biotinylated antisense oligomers (ASOs) complementary to the
junction of circSamd4 and control (Ctrl) were incubated with C2C12 in GM as well as in DM. After affinity pulldown using streptavidin beads, circSamd4-
interacting proteins were identified by mass spectroscopy. Right, levels of circSamd4 enrichment in ASO pulldown samples, as assessed by RT-qPCR
analysis of circSamd4 (relative to the enrichment of Gapdh mRNA, a transcript that does not bind the ASOs and encodes a housekeeping protein) in
the pulldown samples. Enrichment in Samd4 mRNA was monitored in parallel. (B) Venn diagram representation of the proteins significantly enriched
in the mass spec datasets identified after pulldown of circSamd4 ASO vs Ctrl ASOs in mouse C2C12 myoblasts (left) and in human KM155 myoblasts
(right) (Supplementary Figure S3; Materials and Methods). 53 proteins were shared in both mass spec datasets (intersection). (C) Pie chart represents
GO functional categories of the 53 proteins at the intersection of both datasets. (D) Top 7 proteins shared in the mass spec datasets from mouse and
human myoblast pulldowns (Supplementary Table S2 and Supplementary Figure S3A and S3B). (E) Western blot analysis of the interaction of circSamd4
with PURA and PURB present in DM and GM lysates, as assessed after biotin-ASO pulldown followed by western blot analysis of PURA and PURB
levels in the pulldown material. Input (In), 5 g of GM or DM lysates (C2C12). (F) The interaction of PURA and PURB with circSamd4 was assessed
as explained in panel (E), except that lysates were treated with RNase A and/or RNase R before pulldown followed by western blot analysis. (G) For
RIP (ribonucleoprotein immunoprecipitation) analysis, IP was performed using DM C2C12 lysates and either IgG (control) antibodies or antibodies
recognizing PURA or PURB; the presence of circSamd4 and Samd4 mRNA (as well as control Gapdh mRNA) in the IP material was measured by RT-
qPCR analysis. Enrichments were normalized to the levels of 18s rRNA. (H) After fractionating nuclei and cytoplasm, RIP analysis was carried out as
explained in (G) to measure the interaction of PURA and PURB with circSamd4 in the nucleus and the cytoplasm. Data in (A,G,H) are the means ±SEM
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Figure 5. PUR proteins predominantly associate with a specific region of circSamd4. (A) Schematic of biotin pulldown of PURA and PURB using
nonoverlapping biotinylated RNAs (each ∼65 nt long) tiling the length of circSamd4. Following incubation of the biotinylated RNAs with C2C12 DM
lysates, bound proteins were pulled down using streptavidin beads and the presence of PURA and PURB was assessed by western blot analysis. Input
(In) was 2 g of DM lysates; Beads only (Beads), no biotinylated RNA. (B, C) Schematic, circSamd4Δ3 bearing a deletion of segment 3. By 24 h after
transfecting HeLa cells with vectors (2 g) to overexpress circSamd4 and circSamd4(Δ3), RIP analysis was used to measure circSamd4 (left graph) and
SAMD4 mRNA (right graph) bound to PURA and PURB relative to the levels of GAPDH mRNA (B). The levels of circSamd4Δ3 and circSamd4 expressed
in HeLa cells 24 h after transfection of plasmids pcDNA3-circSamd43 and pcDNA3-circSamd4, respectively, were measured by RT-qPCR analysis and
normalized to GAPDH mRNA levels (C). (D) Following overexpression of circSamd4 and circSamd4Δ3 as explained in panel (B), biotin-ASO pulldown
was carried out to confirm the interaction of PURA and PURB with circSamd4 in C2C12 lysates as shown by Western blot analysis. The levels of the
housekeeping protein HSP90 were assessed as a background control protein. Input was 2 g of DM lysates. Data in (B,C) are the means ±SEM from three
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ment 3 contains some of the trinucleotides (GGA, AAG,
CGG, CAG) identified by SELEX (38) as being preferen-
tially bound by PURA, although they were not found as
triplet repeats within circSamd4.
Further evidence that endogenous PUR proteins bound
segment 3 was obtained by employing constructs that over-
expressed full-length circSamd4 (pcDNA3-circSamd4) or a
truncated circRNA lacking fragment 3, circSamd4Δ3 (ex-
pressed from pcDNA-circSamd43). To test if fragment 3
was the region of interaction, we did not use C2C12 cells,
as modulating circSamd4 alone had confounding effects on
myogenesis. Instead, we transfected the constructs into hu-
man cervical carcinoma HeLa cells and 24 h later performed
RIP analysis using anti-PURA and anti-PURB antibodies;
as shown (Figure 5B, left), only the full-length circSamd4
was enriched in the PURA and PURB IP samples, as bind-
ing to the truncated RNA circSamd4Δ3 was equivalent to
the binding observed with the empty vector. The interac-
tion of PUR proteins with linear Samd4 mRNA was un-
changed regardless of whether the full-length or the trun-
cated circRNA was overexpressed (Figure 5B, right) fur-
ther supporting the notion that PURA and PURB associ-
ated with segment 3 of circSamd4. Both circSamd4Δ3 and
circSamd4 were expressed at approximately the same lev-
els (Figure 5C). Additional analysis of the consequences
of PURA and PURB interacting with circSamd4 was pur-
sued by overexpressing these plasmids, as well as empty vec-
tor pcDNA3 (Figure 5C) in HeLa cells followed by ASO
pulldown. In keeping with earlier data, both PURA and
PURB were more enriched in pulldowns from cultures ex-
pressing full-length circSamd4 than in cultures expressing
circSamd4Δ3, indicating that this segment was important
for protein binding (Figure 5D). Together, these data sug-
gest that region 3 in circSamd4 is important for efficient
binding of PURA and PURB.
PURA and PURB repress the transcription of Mhc mRNA,
circSamd4 alleviates this repression
While PUR proteins can promote transcription of target
genes, they can also suppress transcription, as shown for
Mhc (34). Accordingly, silencing PURA or PURB in C2C12
myoblasts led to increased expression of both Mhc RNA
(Figure 6A) and MHC protein (Figure 6B), supporting ear-
lier reports that PURA and PURB suppress transcription
of the Mhc gene (34); under these conditions, circSamd4 and
Samd4 mRNA levels remained unaltered. Further evidence
of this regulatory paradigm came from analysis of a het-
erologous luciferase reporter in which the Mhc promoter
drove Gaussia luciferase (GLuc) activity; Renilla luciferase
(RLuc) expressed from the same vector, served as the trans-
fection control. As shown in Figure 6C, silencing of either
PURA or PURB significantly elevated Mhc-driven expres-
sion of luciferase 1.8- and 1.3-fold, respectively, supporting
the notion that PURA and PURB repress MHC expression.
Importantly, the converse did not occur, as circSamd4 si-
lencing in C2C12 cells did not influence the production of
Pura or Purb mRNAs (Figure 6D) or PURA or PURB pro-
teins (Figure 6E). Likewise, overexpression of circSamd4 in
C2C12 cells did not influence the levels of PURA or PURB
(Figure 6F). These data indicate that PURA and PURB re-
press Mhc transcription and hence MHC expression levels.
We then hypothesized that binding of circSamd4 might
impact upon PURA and PURB function. To test this pos-
sibility, we used the luciferase reporter construct in the
presence of either full-length circSamd4 or circSamd4Δ3.
As shown, only expression of full-length circSamd4 was
able to promote reporter gene expression in differentiated
C2C12 cultures, while expression of the deletion mutant
circSamd4Δ3 or the empty vector control failed to do
so (Figure 7A). Furthermore, expression of circSamd4 in-
creased MHC expression in C2C12 cells, while expression
of circSamd4Δ3 did not (Figure 7B). These data suggest
that circSamd4 might be sequestering PURA and PURB
proteins, thereby enabling MHC production during myoge-
nesis, while deletion mutant circSamd4Δ3, by being unable
to bind PURA and PURB, failed to derepress MHC pro-
duction.
To test these possibilities directly, we assessed if circ-
Samd4 influenced the binding of PUR proteins to the
Mhc promoter. Chromatin immunoprecipitation (ChIP)
was performed followed by qPCR analysis (Materials and
Methods) of the conserved Mhc proximal promoter region
containing the dNRE-S elements, a major binding site of
PURA and PURB in C2C12 myoblasts (34). This analysis
revealed that binding of PURA and PURB to the Mhc pro-
moter increased significantly upon depletion of circSamd4
in C2C12 cells under DM conditions (Figures 7C and D),
supporting the view that circSamd4 can relieve the tran-
scriptional inhibition of Mhc transcription by PURA and
PURB. Conversely, overexpression of circSamd4 in C2C12
cells had the opposite effect, as ChIP analysis revealed that
PURA and PURB binding to the Mhc promoter decreased
after circSamd4 overexpression (Figures 7E and F). Col-
lectively, these data support a model whereby in proliferat-
ing myoblasts (GM) PURA and PURB suppress the Mhc
promoter and MHC production. During myogenesis, circ-
Samd4 levels rise and circSamd4 associates with a fraction
of nuclear and/or cytoplasmic PURA and PURB, two tran-
scriptional repressors of the myogenic protein MHC, which
is required for myotube formation. By contributing to the
derepression of MHC production, circSamd4 helps to es-
tablish later stages of myogenesis (Figure 7G).
DISCUSSION
CircRNAs are increasingly recognized as being implicated
in gene regulatory networks influencing development and
disease. Here, we investigated circRNAs associated with
skeletal myogenesis, a process whereby myoblasts differen-
tiate into myotubes. We found that circSamd4 increased ro-
bustly during skeletal muscle differentiation and associated
with PURA and PURB, two proteins that bind and tran-
scriptionally repress the Mhc promoter and thereby sup-
press myogenic differentiation. We propose a model (Figure
7G) in which circSamd4, accumulating during myogenesis,
associates with PURA and PURB, thereby contributing at
least in part to the derepression of Mhc transcription, the
rise in MHC levels, and the promotion of myogenesis. To
support this model, we present evidence that silencing circ-
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Figure 6. PUR proteins suppress MHC production transcriptionally. (A, B) C2C12 myoblasts were transfected with siRNAs to silence PURA and PURB;
48 h later, the levels of circSamd4, Samd4 mRNA, and Mhc mRNA were assessed by RT-qPCR analysis and normalized to Gapdh mRNA (A). Western blot
analysis was used to evaluate the levels of PURA, PURB, MEF2C, MHC, and loading control HSP90 (B). (C) Schematic of the Mhc promoter reporter
construct (pmh2-GLuc-RLuc) (GeneCopoeia Inc.) used to evaluate MHC transcription. GM C2C12 cells were transfected with 1 g of plasmid pmh2-
GLuc-RLuc in cells expressing normal levels or silenced PURA and PURB as explained in panel (A); 8 hours later, cells were switched to DM media, and
24 h after that, promoter activity was measured. GLuc levels were normalized to RLuc levels in each group; data were then plotted as the difference in
GLuc/RLuc ratios in the Ctrl siRNA transfection group compared with PURA or PURB silencing groups. (D) C2C12 cells were transfected with control
(Ctrl) siRNA or circSamd4 siRNA; 48 h later, the expression levels of Pura and Purb mRNAs, normalized to the levels of Gapdh RNA, were measured by
RT-qPCR analysis and plotted. (E, F) Effect of silencing circSamd4 on the expression of PURA, PURB, and MHC; 48 h after transfecting GM C2C12
cells with control (Ctrl) siRNA or circSamd4 siRNA, the levels of circSamd4, and Samd4, Pura, and Purb mRNAs were assessed by RT-qPCR analysis
(E) and the levels of proteins PURA, PURB, MHC, and loading control HSP90 by western blot analysis (F). Data in (A,C,D) are the means ±SEM from
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Figure 7. circSamd4 binds PUR proteins, derepressing Mhc gene transcription. (A) Activity of the Mhc promoter, as determined by monitoring luciferase
activity after transfecting 500 ng of reporter pMH2-LUC-Renilla (Figure 6C) into C2C12 cells that had been transfected 24 h earlier with parent vector
pcDNA3 or with vectors expressing circSamd4 or circSamd4-Δ3 (left graph). Eight h after transfection of the reporter construct, the cells were switched
to DM media for 24 h and promoter activity was measured; as above (Figure 6C), GLuc was normalized to RLuc and these ratios were plotted relative to
the ratios measured in the empty vector group (right graph). (B) The levels of MHC in the different transfection groups shown in panel (A) were assessed
by western blot analysis and HSP90 levels were shown as the loading control. (C–F) ChIP-qPCR analysis of the association of PURA and PURB with the
Mhc proximal promoter region (−270/−450). Following crosslinking (Materials and Methods), antibodies recognizing PURA (C, E) or PURB (D, F) or
control nonspecific rabbit IgG antibodies were used to immunoprecipitate sheared chromatin from C2C12 myoblasts in which circSamd4 was silenced (C,
D) or overexpressed (E, F). Specific oligonucleotide primers were used to amplify the region of interaction with PURA and PURB. ChIP-qPCR data were
calculated using percentage of input; the TTS region of the neuron-specific gene Syn2 (region +200 TTS), which encodes the protein SYN2 (Synapsin),
was assayed as a non-target negative control. (G) Summary model. In myoblasts (GM), virtually undetectable levels of circSamd4 permit the repression of
the Mhc promoter by PURA and PURB. As myogenesis progresses (DM), the rise in circSamd4 leads to binding of a fraction of PURA and PURB away
from the Mhc promoter, thereby helping to derepress Mhc transcription and enabling the accumulation of Mhc mRNA and the production of MHC, a key
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genic factors (e.g. Myog, Mef2c and Mhc mRNAs, as well as
the encoded proteins) (Figure 3) and helped to preserve the
binding of PURA and PURB to the Mhc promoter (Fig-
ure 7C and D), keeping MHC levels low; conversely, over-
expression of circSamd4 lowered PURA and PURB bind-
ing to the Mhc promoter and increased MHC production
(Figure 7B, E and F). A mutant circSamd4 lacking the site
of interaction with PURA/B (circSamd4Δ3) was unable to
rescue the effects of circSamd4 on myogenesis.
The mechanism whereby circSamd4 promotes myoge-
nesis remains to be studied in molecular detail. For ex-
ample, how specifically the production of circSamd4 from
Samd4 pre-mRNA rises during differentiation while Samd4
mRNA levels rise comparatively less (Figure 2). The pos-
sible involvement of myogenic splicing factors in the pro-
duction of circSamd4 is not known at present. Whether
some of the additional circSamd4-binding proteins that
have splicing activity, such as HNRNPM (Figure 4D),
TRA2B, SRSF6 or others (Supplementary Figure S4A, B;
Supplementary Table S2) are implicated in the generation
of circSamd4 also warrants future investigation.
The lower abundance of circSamd4 in the nucleus (es-
timated at ∼2 molecules) suggests that nuclear circSamd4
cannot alone suppress the binding of all of the nuclear
PURA and PURB to the Mhc promoter. Instead, circ-
Samd4 likely cooperates with other factors to prevent the
transcriptional repression of Mhc by PURA and PURB,
even though these cooperating factors were not identified in
this study. Alternatively, given that cytoplasmic circSamd4
is more abundant (∼20-fold than the nuclear circSamd4;
Figure 2D and E), it is possible that circSamd4 binds to and
sequesters PURA/B in the cytoplasm, and thus it prevents
PURA/B from repressing Mhc transcription in the nucleus,
or perhaps circSamd4 helps export PUR proteins to the cy-
toplasm. Supporting these possibilities, PURA and PURB
were also found to reside in both compartments (supple-
mentary Figure S4F) and circSamd4 was found to interact
with PUR proteins in both the nucleus and the cytosol (Fig-
ure 4H). Additional related questions that warrant study in
biochemical detail include how the affinity of PURA and
PURB for circSamd4 compares to its affinity for the Mhc
promoter during myogenesis. In a recent study, circSAMD4
was found to promote osteosarcoma by associating with mi-
croRNA miR-1244 (33). Whether PURA and PURB bind-
ing influences the binding of myogenic microRNAs to circ-
SAMD4 or circSamd4 also deserves future study.
PURA and PURB are highly conserved proteins, from
bacteria to mammals, and are found in virtually every tissue
(www.genecards.org), although PURA appears to be more
abundant. The PUR protein family also includes PURG,
although PURG was not found to bind circSamd4 in our
screen, and it seems less abundant in tissues overall. PURA
and PURB interact with both single-stranded DNA and
RNA and influence molecular processes such as DNA repli-
cation, gene transcription, cytoplasmic RNA transport,
and compartmentalized mRNA translation (39,40). Besides
mRNAs, PURA was found to interact with lncRNA BC1 in
rodents and the cognate lncRNA BC200 in humans (41,42),
as well as with other proteins (43). It will be interesting to
study whether circSamd4 mobilizes PURA and PURB to
the cytoplasm of myoblasts and enables cytoplasmic func-
tions for PURA and PURB in mRNA transport or trans-
lation, particularly during later stages of myogenesis when
MHC is strongly expressed.
Previous work indicated that PUR proteins repressed the
transcription of α-MHC mRNA and the translation of -
MHC in cardiac myocytes and may thus prevent its expres-
sion in non-muscle cells (35). In this regard, it will also be
important to establish the possible impact of PURA and
PURB, and by extension of circSamd4, on the production
of the different sarcomeric MHC gene variants (34) and
to find out if other promoters inhibited by PUR proteins
are also derepressed by an increase in circSamd4 levels. In
addition, endogenous PURA and PURB were necessary
to fully repress full-length smooth muscle ACTA (-Actin)
promoter in cultured fibroblasts but to a lesser extent in vas-
cular smooth muscle cells (44). Indeed, the effects of PUR-
circSamd4-mediated gene regulation may be broadly rele-
vant to other tissue types such as cardiomyocytes, fibrob-
lasts, neurons, myeloid cells, and vascular smooth muscle
cells in which PUR proteins are expressed and are func-
tional (35,40,44,45).
Future studies analyzing comprehensively circSamd4-
interacting proteins and RNAs may uncover its role in skele-
tal muscle formation and in muscle disorders such as my-
otonic dystrophy (DM) and facioscapulohumeral muscular
dystrophy (FSHD). As several chronic skeletal muscle dys-
functions are associated with changes in MHC production,
interventions to modulate circSamd4 function may be ther-
apeutically valuable in disease conditions. Finally, work is
underway to understand the mechanisms driving the age-
dependent decline in MHC levels, given that circSAMD4
abundance increases with age (Supplementary Figure S1D).
A comprehensive understanding of circSamd4 biogenesis,
interaction partners, and impact on myogenic gene expres-
sion programs will guide novel circRNA-centered interven-
tions in age- and disease-associated loss of muscle function.
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